Sham Control: Clinical Trials

80 trials of Sham Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 15 unknown, 11 recruiting, 8 not yet recruiting. 57 Not applicable, 9 Phase 2, 9 Phase 3, 5 Phase 1, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable57Completed 30, Recruiting 11, Unknown 8, Not yet recruiting 6, Terminated 1, Withdrawn 1
Phase 29Completed 5, Terminated 2, Unknown 2
Phase 39Completed 4, Unknown 3, Terminated 2
Phase 15Completed 2, Unknown 2, Not yet recruiting 1
Early Phase 13Completed 1, Not yet recruiting 1, Unknown 1

Follow Sham Control: new trials by email Literature Review of Sham Control trials Research Report on Sham Control

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease
TG-C High Dose, TG-C Mid Dose, TG-C Low Dose - Degenerative Disc Disease
Phase 1Not yet recruitingKolon TissueGene, Inc.242027-01-192026-08-20
Brief Bronchial Suction for Lung Collapse During Uniportal VATS
bronchial suction, Sham Control - Lung Collapse, One-lung Ventilation
Not applicableNot yet recruitingMahidol University1002026-11-012026-10-07
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Implantation of the V-Wave Interatrial shunt, Sham (no implant) - Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Not applicableNot yet recruitingV-Wave Ltd2502026-09-302026-07-10
AVE-Neurofeedback for Academic Anxiety and Divergent Thinking
Audiovisual Entrainment Neurofeedback (AVE-NFB), Neurofeedback Only, Audiovisual Entrainment - Academic Anxiety, Test Anxiety
Not applicableRecruitingDaniswara Raditya Suprapto2402026-09-042026-09-02
Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults
Exercise, Sham Control - Frailty Syndrome, Older Adults
Not applicableRecruitingTaipei Medical University302026-08-192026-10-05
Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly
Catheter Ablation, Sham Control - Atrial Fibrillation (AF)
Not applicableRecruitingBeijing Anzhen Hospital1362026-07-012026-07-06
Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy
AGX-08-L, AGX-08-H, AGX-08-S - Geographic Atrophy
Early Phase 1Not yet recruitingZhongmou Therapeutics242026-07-012026-07-31
The REVIVE Pivotal Study
Ryme TLD, Sham Control - COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbations
Not applicableNot yet recruitingRyme Medical, Inc.3002026-06-012026-05-05
Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation
Game-Based Electromyographic (EMG) Biofeedback Therapy, Sham Control - Defecation Disorder
Not applicableRecruitingKocaeli University362026-03-312026-08-07
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
Right Greater Splanchnic Nerve (GSN) ablation, Sham Control - Heart Failure With Reduced Ejection Fraction (HFrEF)
Not applicableNot yet recruitingAxon Therapies, Inc.502026-03-012026-02-11
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
transcutaneous auricular vagus nerve stimulation, Sham Control - Presbycusis
Not applicableCompletedUniversity of Florida362025-12-012026-10-20
Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI
Olfactory stimulation, Temporal Interference,TI, Olfactory-TI Stimulation - MCI-AD, Early Stage Alzheimer's Disease
Not applicableNot yet recruitingYuan Shen3002025-10-012025-09-29
Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia
Cardioneuroablation, Sham Control - Symptomatic Bradycardia, Autonomic Nervous System Diseases
Not applicableRecruitingBeijing Anzhen Hospital1882025-08-012026-03-13
Photobiomodulation in Radiodermatitis in People With Breast Cancer
Photobiomodulation, Sham Control - Breast Cancer, Radio Dermatitis
Not applicableNot yet recruitingInstituto Nacional de Cancer, Brazil1482025-05-012025-05-25
Standard Urotherapy for Dysfunctional Voiding in Children
Standard urotherapy (SUT) alone., Sham control - Dysfunctional Voiding, Medical Treatment
Not applicableCompletedTanta University1402025-02-262026-08-03
Heat thErapy And mobiLity in COVID-19 Survivors
Heat therapy, Sham Control, Walking - Long COVID
Not applicableRecruitingUniversity of Nebraska992025-01-162026-09-28
Effects of Exposure to a Single-electrode Electroencephalography-guided Binaural Beat Audio Track on Sustained Attention and Subjective Well-being Among Healthy Adults
EEG-Guided Binaural Beat Audio, Sham Control - Psychomotor Speed, Sustained Attention
Not applicableCompletedTexas Tech University Health Sciences Center252024-08-162025-09-10
The METRIC Study Protocol
lumbar spinal manipulative therapy, sham spinal manipulative therapy, full spine spinal manipulative therapy - Chronic Low-back Pain
Not applicableRecruitingUniversité du Québec à Trois-Rivières1122023-10-252023-12-04
Effects of Intravascular Laser Irradiation of Blood for Mitochondral Dysfunction in Cerebral Ischemic Stroke
ILIB, Sham Control - Ischemic Stroke
Not applicableCompletedTri-Service General Hospital (TSGH)82023-08-012025-04-17
Contingency Management for Drug Use: Does Age Matter?
DynamiCare app (app-based contingency management), Sham control - Opioid Use Disorder, Methamphetamine Abuse
Not applicableCompletedWake Forest University Health Sciences622023-05-012026-08-18

Showing 20 of 80. Sign in to see all of them.

Conditions studied

Hypertension (4)  ·  Ischemic Stroke (4)  ·  Tobacco Use Disorder (4)  ·  Heart Failure (3)  ·  Stroke (3)  ·  Brain Injuries, Traumatic (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Geographic Atrophy (2)  ·  Hyperthermia (2)  ·  Inflammation (2)  ·  Intervertebral Disc Degeneration (2)  ·  Opioid-Related Disorders (2)  ·  Post-Acute COVID-19 Syndrome (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Respiratory Tract Infections (2)

Sponsors

University of California, Los Angeles (4)  ·  Novartis Pharmaceuticals (3)  ·  Seoul National University Hospital (3)  ·  Arizona State University (2)  ·  Axon Therapies, Inc. (2)  ·  Beijing Anzhen Hospital (2)  ·  University of Florida (2)  ·  Wake Forest University Health Sciences (2)  ·  Ablative Solutions, Inc. (1)  ·  Ariel University (1)  ·  Baker Heart and Diabetes Institute (1)  ·  BrainsGate (1)  ·  Broncus Technologies (1)  ·  Chang Gung Memorial Hospital (1)  ·  Children's ENT of San Diego, Inc. (1)

Countries

United States (32)  ·  Canada (8)  ·  Germany (8)  ·  United Kingdom (7)  ·  Australia (6)  ·  South Korea (6)  ·  Brazil (5)  ·  China (5)  ·  Spain (5)  ·  Taiwan (5)  ·  Czechia (4)  ·  France (4)  ·  Singapore (4)  ·  Belgium (3)  ·  Israel (3)

Top investigators

Alain Ades, MD (1)  ·  Alfonso Torquati, MD (1)  ·  Anke Bergmann, PhD (1)  ·  Ariel Zucher, PhD (1)  ·  Ariel Zucker, PhD (1)  ·  Atul Pathak, Prof. (1)  ·  Carl LeBel, PhD (1)  ·  Changsheng Ma, Prof. (1)  ·  Charles Filipi, MD (1)  ·  Charles Lightdale, MD (1)  ·  Chih-Ming Cheng, M.D. (1)  ·  Christian Lamer, MD (1)  ·  Christian Seiler, Prof (1)  ·  Christopher Centeno, MD (1)

Results publications

PMID 16530506, PMID 16952539, PMID 17294322, PMID 17368232, PMID 20179692, PMID 21214899, PMID 21907863, PMID 22908836, PMID 25181050, PMID 25835112, PMID 28059942, PMID 29895590, PMID 30180887, PMID 32958438, PMID 33397772, PMID 33739123, PMID 33893763, PMID 34129127, PMID 34402352, PMID 34806762, PMID 36349701, PMID 38020175, PMID 38211934, PMID 38321811, PMID 38968979, PMID 39231380, PMID 39356530, PMID 39526682, PMID 40315243, PMID 40709601, PMID 41360993, PMID 42518791

NIH funding

2018 (1), R01AG073634 (1), R01AG089307 (1)